A Study to Evaluate EDG-7500 in Caucasian and Japanese Adults

Clinical trial NCT07456059 · COMPLETED

Trial details

NCT number: NCT07456059
Sponsor: Edgewise Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2026-03-10
Primary completion: 2026-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.